PROSPER: Phase III RandOmized Study Comparing PERioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).

Authors

null

Mohamad E. Allaf

James Buchanan Brady Urological Institute, Dept. of Urology, Johns Hopkins University School of Medicine, Baltimore, MD

Mohamad E. Allaf , Se Eun Kim , Viraj A. Master , David F. McDermott , Sabina Signoretti , David Cella , Rajan T. Gupta , Suzanne Cole , Brian M. Shuch , Primo "Lucky" N. Lara Jr., Anil Kapoor , Daniel Yick Chin Heng , Bradley C. Leibovich , M. Dror Michaelson , Toni K. Choueiri , Michael A.S. Jewett , Deb Maskens , Lauren C Harshman , Michael Anthony Carducci , Naomi B. Haas

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

NCT03055013

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS4596)

DOI

10.1200/JCO.2021.39.15_suppl.TPS4596

Abstract #

TPS4596

Poster Bd #

Online Only

Abstract Disclosures